Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review

Julie Fu; Jenica Upshaw; Joshua Cohen; Angie Mae Rodday; Tully Saunders; Michael Kelly; Andrew M Evens; Susan K Parsons

doi:10.1080/10428194.2017.1406086

Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review

Leuk Lymphoma. 2018 Aug;59(8):1976-1980. doi: 10.1080/10428194.2017.1406086. Epub 2017 Dec 7.

Authors

Julie Fu^{1

2

3

4}, Jenica Upshaw^{3

5}, Joshua Cohen^{3

6}, Angie Mae Rodday^{2

3}, Tully Saunders², Michael Kelly^{3

7}, Andrew M Evens^{1

3}, Susan K Parsons^{1

2

3}

Affiliations

¹ a Division for Hematology/Oncology , Tufts Medical Center , Boston , MA , USA.
² b Center for Health Solutions, Institute for Clinical Research and Health Policy Studies (ICRHPS) , Tufts Medical Center , Boston , MA , USA.
³ c Tufts University School of Medicine , Boston , MA , USA.
⁴ d Tufts Medical Center Cancer Center of Stoneham , Stoneham , MA , USA.
⁵ e CardioVascular Center , Tufts Medical Center , Boston , MA , USA.
⁶ f Center for the Evaluation of Value and Risk in Health (ICRHPS) , Tufts Medical Center , Boston , MA , USA.
⁷ g Division of Pediatric Hematology/Oncology , Floating Hospital for Children at Tufts Medical Center , Boston , MA , USA.

PMID: 29214876
DOI: 10.1080/10428194.2017.1406086

No abstract available

Publication types

Letter
Systematic Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Chemoradiotherapy / adverse effects
Chemoradiotherapy / methods
Heart Diseases / diagnosis*
Heart Diseases / etiology
Hodgkin Disease / drug therapy*
Hodgkin Disease / therapy*
Humans
Risk Assessment
Risk Factors
Treatment Outcome